ESR1 and breast cancer: Triple-negative breast cancer (TNBC) is a molecular subtype of breast cancer characterized by the lack of immunohistochemical staining for estrogen receptors (ER), progesterone receptors (PR), and lack of overexpression or amplification of human epidermal growth factor receptor 2 (HER2) [2–4].